BioClinica Technologies
ICL Technology Solutions
Only BioClinica has the know-how and flexibility to design and manage a protocol specific independent read system. At the heart of BioClinica ICL Technology Solutions is a deep understanding of the complexities and differences among the three major independent read scenarios:
Eligibility — using imaging to determine inclusion or exclusion of the patient into your trial.
Efficacy — using imaging to support your trial’s primary and/or secondary endpoints.
Safety — using imaging to evaluate your trial’s safety profile.
No matter which independent read scenario your trial fits into, we can provide state-of-the-art imaging core lab ICL technology solutions that are designed to make your clinical trial a success. Our broad suite of proprietary clinical trial management software features multiple input controls and logistic checks, to help you keep a watchful eye on your project, and can facilitate the accurate and real-time tracking of your trial’s imaging data.
Our truly independent reads and ICL technology deliver reliable results.
BioClinica’s ICL technology solutions allow the images to be displayed in a completely blinded fashion, thereby eliminating potential bias associated with the review. The radiologists selected for these reads are all licensed, board-certified experts — many of whom hold fellowship training in their respective therapeutic area and meet all FDA requirements as independent consultant readers. We select a minimum of two experienced independent readers from different institutions for your clinical trial management system. The radiologists are selected either by the client or from BioClinica’s network of radiologists. Curricula vitae are available for client review and approval prior to the final selection of the readers.
BioClinica’s full suite of proven ICL clinical trial software includes: